Alzheimer's disease-related biomarkers and cancer-related cognitive decline: the thinking and living with cancer study.

Jeanne S MandelblattJeffrey L DageXingtao ZhouBrent J SmallTim A AhlesJaeil AhnAshley ArteseTraci N BetheaElizabeth C BreenJudith E CarrollHarvey J CohenMartine ExtermannDeena GrahamClaudine IsaacsHeather S L JimBrenna C McdonaldZev M NakamuraSunita K PatelG William RebeckKelly E RentscherJames C RootKristen A RussDanielle B TometichR Scott TurnerKathleen Van DykWanting ZhaiLi-Wen HuangAndrew J Saykin

Published in: Journal of the National Cancer Institute (2024)

The results do not support a relationship between baseline AD-related biomarkers and CRCD. Further investigation is warranted to confirm the findings, test effects of longitudinal changes in AD-related biomarkers and examine other mechanisms and factors affecting cognition pre-systemic therapy.

Keyphrases

cognitive decline
mild cognitive impairment
stem cells
squamous cell carcinoma
cross sectional
mesenchymal stem cells
replacement therapy